{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:20:00Z","timestamp":1787167200532,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T00:00:00Z","timestamp":1563235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012093","name":"Fundaci\u00f3 Institut de Recerca Hospital Universitari Vall d\u2019Hebron","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013465","name":"French Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["19,965"],"award-info":[{"award-number":["19,965"]}],"id":[{"id":"10.13039\/100013465","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["SLT002\/16\/00370"],"award-info":[{"award-number":["SLT002\/16\/00370"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI15\/00465"],"award-info":[{"award-number":["PI15\/00465"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PMP 15\/00025"],"award-info":[{"award-number":["PMP 15\/00025"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010198","name":"Ministerio de Asuntos Econ\u00f3micos y Transformaci\u00f3n Digital, Gobierno de Espa\u00f1a","doi-asserted-by":"publisher","award":["BFU2014-52618-R"],"award-info":[{"award-number":["BFU2014-52618-R"]}],"id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010198","name":"Ministerio de Asuntos Econ\u00f3micos y Transformaci\u00f3n Digital, Gobierno de Espa\u00f1a","doi-asserted-by":"publisher","award":["SAF2017-87506-R"],"award-info":[{"award-number":["SAF2017-87506-R"]}],"id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.ebiom.2019.07.042","type":"journal-article","created":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T01:24:08Z","timestamp":1563931448000},"page":"342-355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Age-related metabolic changes limit efficacy of deoxynucleoside-based therapy in thymidine kinase 2-deficient mice"],"prefix":"10.1016","volume":"46","author":[{"given":"Cora","family":"Bl\u00e1zquez-Bermejo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Molina-Granada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferran","family":"Vila-Juli\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Jim\u00e9nez-Heis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Torres-Torronteras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Mart\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2458-6942","authenticated-orcid":false,"given":"Yolanda","family":"C\u00e1mara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2019.07.042_bb0005","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1093\/hmg\/ddn143","article-title":"Thymidine kinase 2 (H126N) knockin mice show the essential role of balanced deoxynucleotide pools for mitochondrial DNA maintenance","volume":"17","author":"Akman","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ebiom.2019.07.042_bb0010","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1212\/01.wnl.0000436931.94291.e6","article-title":"Late-onset respiratory failure due to TK2 mutations causing multiple mtDNA deletions","volume":"81","author":"Alston","year":"2013","journal-title":"Neurology."},{"key":"10.1016\/j.ebiom.2019.07.042_bb0015","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1093\/hmg\/ddq043","article-title":"Loss of thymidine kinase 2 alters neuronal bioenergetics and leads to neurodegeneration","volume":"19","author":"Bartesaghi","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ebiom.2019.07.042_bb0020","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/hmg\/ddt641","article-title":"Administration of deoxyribonucleosides or inhibition of their catabolism as a pharmacological approach for mitochondrial DNA depletion syndrome","volume":"23","author":"Camara","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ebiom.2019.07.042_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005779","article-title":"MPV17 loss causes deoxynucleotide insufficiency and slow DNA replication in mitochondria","volume":"12","author":"Dalla Rosa","year":"2016","journal-title":"PLoS Genet"},{"key":"10.1016\/j.ebiom.2019.07.042_bb0030","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/ana.25506","article-title":"Deoxynucleoside therapy for thymidine kinase 2 (TK2) deficient myopathy","volume":"86","author":"Dominguez-Gonzalez","year":"2019","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ebiom.2019.07.042_bb0035","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/hmg\/ddq453","article-title":"Onset and organ specificity of Tk2 deficiency depends on Tk1 down-regulation and transcriptional compensation","volume":"20","author":"Dorado","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ebiom.2019.07.042_bb0040","first-page":"3687","article-title":"Differences in activities and substrate specificity of human and murine pyrimidine nucleoside phosphorylases: implications for chemotherapy with 5-fluoropyrimidines","volume":"53","author":"el Kouni","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.ebiom.2019.07.042_bb0045","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/0006-2952(86)90160-7","article-title":"Kinetics and substrate specificity of human and canine cytidine deaminase","volume":"35","author":"Fanucchi","year":"1986","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ebiom.2019.07.042_bb0050","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.15252\/emmm.201404092","article-title":"Deoxypyrimidine monophosphate bypass therapy for thymidine kinase 2 deficiency","volume":"6","author":"Garone","year":"2014","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.ebiom.2019.07.042_bb0055","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1136\/jmedgenet-2017-105012","article-title":"Retrospective natural history of thymidine kinase 2 deficiency","volume":"55","author":"Garone","year":"2018","journal-title":"J Med Genet"},{"key":"10.1016\/j.ebiom.2019.07.042_bb0060","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/brain\/awn236","article-title":"Thymidine kinase 2 defects can cause multi-tissue mtDNA depletion syndrome","volume":"131","author":"Gotz","year":"2008","journal-title":"Brain."},{"key":"10.1016\/j.ebiom.2019.07.042_bb0065","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s11373-007-9175-1","article-title":"Mitotic control of dTTP pool: a necessity or coincidence?","volume":"14","author":"Hu","year":"2007","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.ebiom.2019.07.042_bb0070","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1096\/fj.06-7272com","article-title":"Hiding human thymidine kinase 1 from APC\/C-mediated destruction by thymidine binding","volume":"21","author":"Ke","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.ebiom.2019.07.042_bb0075","doi-asserted-by":"crossref","first-page":"32835","DOI":"10.1074\/jbc.M114.588921","article-title":"Long term expression of Drosophila melanogaster nucleoside kinase in thymidine kinase 2-deficient mice with no lethal effects caused by nucleotide pool imbalances","volume":"289","author":"Krishnan","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ebiom.2019.07.042_bb0080","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/ana.24922","article-title":"Deoxycytidine and Deoxythymidine treatment for thymidine kinase 2 deficiency","volume":"81","author":"Lopez-Gomez","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ebiom.2019.07.042_bb0085","article-title":"Bioavailability and activities of cytosolic kinases modulate response to deoxynucleoside therapy in TK2 deficiency","volume":"2019","author":"Lopez-Gomez","year":"2019","journal-title":"Submitted"},{"key":"10.1016\/j.ebiom.2019.07.042_bb0090","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/hmg\/ddn401","article-title":"Unbalanced deoxynucleotide pools cause mitochondrial DNA instability in thymidine phosphorylase-deficient mice","volume":"18","author":"Lopez","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ebiom.2019.07.042_bb0095","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-1-61779-504-6_8","article-title":"Assessment of thymidine phosphorylase function: measurement of plasma thymidine (and deoxyuridine) and thymidine phosphorylase activity","volume":"837","author":"Marti","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.ebiom.2019.07.042_bb0100","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1096\/fj.06-5730rev","article-title":"DNA precursor metabolism and genomic stability","volume":"20","author":"Mathews","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.ebiom.2019.07.042_bb0105","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/j.2040-4603.2018.tb00034.x","article-title":"Intestinal nucleoside transporters: function, expression, and regulation","volume":"8","author":"Pastor-Anglada","year":"2018","journal-title":"Compr Physiol"},{"key":"10.1016\/j.ebiom.2019.07.042_bb0110","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mrgentox.2010.06.002","article-title":"Regulation by degradation, a cellular defense against deoxyribonucleotide pool imbalances","volume":"703","author":"Rampazzo","year":"2010","journal-title":"Mutat Res"},{"issue":"2","key":"10.1016\/j.ebiom.2019.07.042_bb0115","article-title":"Expression and functional activity of nucleoside transporters in human choroid plexus","volume":"7","author":"Redzic","year":"2010","journal-title":"Cerebrospinal Fluid Res"},{"key":"10.1016\/j.ebiom.2019.07.042_bb0120","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bcp.2007.03.029","article-title":"Expression of deoxynucleoside kinases and 5\u2032-nucleotidases in mouse tissues: implications for mitochondrial toxicity","volume":"74","author":"Rylova","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ebiom.2019.07.042_bb0125","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/ng751","article-title":"Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy","volume":"29","author":"Saada","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.ebiom.2019.07.042_bb0130","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.bbrc.2003.09.104","article-title":"Mitochondrial deoxyribonucleoside triphosphate pools in thymidine kinase 2 deficiency","volume":"310","author":"Saada","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ebiom.2019.07.042_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1096-7192(03)00063-5","article-title":"mtDNA depletion myopathy: elucidation of the tissue specificity in the mitochondrial thymidine kinase (TK2) deficiency","volume":"79","author":"Saada","year":"2003","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ebiom.2019.07.042_bb0140","first-page":"196","article-title":"Deoxynucleoside and vitamin transport into the central nervous system","volume":"43","author":"Spector","year":"1984","journal-title":"Fed Proc"},{"key":"10.1016\/j.ebiom.2019.07.042_bb0145","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/hmg\/ddr438","article-title":"Thymidine kinase 2 mutations in autosomal recessive progressive external ophthalmoplegia with multiple mitochondrial DNA deletions","volume":"21","author":"Tyynismaa","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ebiom.2019.07.042_bb0150","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/135965350601100109","article-title":"Uridine abrogates the adverse effects of antiretroviral pyrimidine analogues on adipose cell functions","volume":"11","author":"Walker","year":"2006","journal-title":"Antivir Ther"},{"key":"10.1016\/j.ebiom.2019.07.042_bb0155","doi-asserted-by":"crossref","first-page":"6963","DOI":"10.1074\/jbc.M206143200","article-title":"Kinetic properties of mutant human thymidine kinase 2 suggest a mechanism for mitochondrial DNA depletion myopathy","volume":"278","author":"Wang","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ebiom.2019.07.042_bb0160","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1080\/15257770.2015.1125001","article-title":"Mitochondrial purine and pyrimidine metabolism and beyond","volume":"35","author":"Wang","year":"2016","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.ebiom.2019.07.042_bb0165","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1042\/BST20160038","article-title":"The SLC28 (CNT) and SLC29 (ENT) nucleoside transporter families: a 30-year collaborative odyssey","volume":"44","author":"Young","year":"2016","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.ebiom.2019.07.042_bb0170","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1093\/hmg\/ddn133","article-title":"Progressive loss of mitochondrial DNA in thymidine kinase 2-deficient mice","volume":"17","author":"Zhou","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ebiom.2019.07.042_bb0175","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11302-012-9309-4","article-title":"Cellular function and molecular structure of ecto-nucleotidases","volume":"8","author":"Zimmermann","year":"2012","journal-title":"Purinergic Signal"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419304840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419304840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:54:46Z","timestamp":1762455286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396419304840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":35,"alternative-id":["S2352396419304840"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.07.042","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Age-related metabolic changes limit efficacy of deoxynucleoside-based therapy in thymidine kinase 2-deficient mice","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.07.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}